Normark S, Grundström T, Bergström S
Scand J Infect Dis Suppl. 1980;suppl 25:23-9.
The genetic and physiological mechanisms for affecting the amount of chromosomally mediated beta-lactamase of Escherichia coli K 12 was reviewed. The presence of clinical E. coli isolates with elevated beta-lactamase production was assessed. Among cephalothin resistant isolates from patients with urinary tract infections, six E. coli strains were found to produce elevated amounts of a beta-lactamase indistinguishable from that coded by the ampC gene of E. coli K 12. The resistance levels displayed by these isolates towards a number of beta-lactams was very high as compared to E. coli strains being wild type for chromosomal beta-lactamase production. Cefuroxime and to lesser extent cefamandole were stable to hydrolysis by E. coli chromosomal beta-lactamase but acted as inhibitors of the enzyme. Nevertheless increased beta-lactamase production mediated an increased resistance towards these drugs.
本文综述了影响大肠杆菌K12染色体介导的β-内酰胺酶产量的遗传和生理机制。评估了产β-内酰胺酶水平升高的临床大肠杆菌分离株的存在情况。在尿路感染患者的头孢噻吩耐药分离株中,发现6株大肠杆菌产生的β-内酰胺酶量升高,与大肠杆菌K12的ampC基因编码的β-内酰胺酶无法区分。与染色体β-内酰胺酶产生为野生型的大肠杆菌菌株相比,这些分离株对多种β-内酰胺类药物的耐药水平非常高。头孢呋辛以及程度较轻的头孢孟多对大肠杆菌染色体β-内酰胺酶的水解作用稳定,但可作为该酶的抑制剂。然而,β-内酰胺酶产量的增加介导了对这些药物耐药性的增加。